Elenco degli articoli con argomento «vitiligine»
Dermatologia04 mag 2023
Terapie in arrivo ad hoc per la vitiligine
Picardo (Sidemast): "Finora era considerata una non-malattia ed era orfana di trattamenti specifici"
04 mag 2023
Per la cura della vitiligine terapie innovative una task force e Sidemast
Sono finalmente in arrivo terapie ad hoc per la vitiligine, una patologia che colpisce tra l’1 e il 2% della popolazione mondiale
20 feb 2023
A Review on the Safety of Using JAK Inhibitors in Dermatology
Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions
03 ott 2022
FDA approves Ruxolitinib
The Food and Drug Administration (FDA) has authorized Ruxolitinib (Opzelura)
06 giu 2022
British Association of Dermatologists guidelines
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of vitiligo
30 mag 2022
The use of lasers in vitiligo
Various types of lasers have been demonstrated to be effective in the treatment of vitiligo.
11 apr 2022
The Humanistic Burden of Vitiligo
Despite historical mischaracterization as a cosmetic condition, patients with the autoimmune disorder vitiligo experience substantial quality-of-life (QoL) burden.
21 feb 2022
Association between vitiligo and hearing loss
Vitiligo is a common depigmenting disorder caused by the autoimmune destruction of melanocytes.
13 set 2021
Vitiligo: an update on systemic treatments
Vitiligo is an autoimmune skin condition characterized by depigmented macules and patches, and has a huge psychosocial impact on patients.
07 giu 2021
Resident Memory T Cells
Tissue resident memory T cells (TRM) are a critical component of the immune system
16 mar 2021
Vitiligo
Vitiligo is an autoimmune skin condition characterized by depigmented macules and patches, and has a huge psychosocial impact on patients.
24 nov 2020
Autoimmunity in Segmental Vitiligo
The autoimmune basis of segmental vitiligo (SV) has only recently been recognized.
14 set 2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Vitiligo is a chronic autoimmune disease resulting in skin depigmentation and reduced quality of life.
14 apr 2020
Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy
systematic review and Meta-analysis
17 nov 2019
La vitigline: trattasi di patologia piuttosto rara e particolare
La vitigline, è una patologia dermatologica piuttosto rara e particolare, c’è chi l’ha trasformata in un punto di forza.
29 ott 2019
Vitiligine: malattia autoimmune con pesanti ripercussioni psicologiche
Colpisce uomini, donne e bambini. E’ dovuta alla scomparsa localizzata dei melanociti, cellule responsabili della pigmentazione della pelle
03 giu 2019
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients
Panniculitis and vitiligo-like lesions have been recently identified as rare cutaneous side effects of the combination of BRAF and MEK inhibitors, a standard of care in metastatic and locally advanced BRAF V600 mutated melanoma.
22 apr 2019
Acquired disorders with depigmentation: A systematic approach to vitiliginoid conditions
Acquired disorders with depigmentation are commonly encountered by dermatologists and present with a wide differential diagnosis
04 dic 2018
Alopecia Areata, spia di altre malattie autoimmuni
Non è pericolosa per la salute, ma può essere la prima espressione di una serie di patologie autoimmuni
11 set 2018
Topical Janus kinase inhibitors: A review of applications in dermatology
J Am Acad Dermatol. 2018 Sep;79(3):535-544.